Cargando…
Application of a Systems Pharmacology-Based Placebo Population Model to Analyze Long-Term Data of Postmenopausal Osteoporosis
Osteoporosis is a progressive bone disease characterized by decreased bone mass resulting in increased fracture risk. The objective of this investigation was to test whether a recently developed disease systems analysis model for osteoporosis could describe disease progression in a placebo-treated p...
Autores principales: | Berkhout, J, Stone, JA, Verhamme, KM, Stricker, BH, Sturkenboom, MC, Danhof, M, Post, TM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592531/ https://www.ncbi.nlm.nih.gov/pubmed/26451331 http://dx.doi.org/10.1002/psp4.12006 |
Ejemplares similares
-
Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women
por: Berkhout, J, et al.
Publicado: (2016) -
Long-Term Treatment of Postmenopausal Osteoporosis
por: Brown, Jacques P.
Publicado: (2021) -
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010) -
Use of Network Pharmacology and Molecular Docking Technology to Analyze the Mechanism of Action of Velvet Antler in the Treatment of Postmenopausal Osteoporosis
por: Guo, Kuiting, et al.
Publicado: (2021) -
Network pharmacology-based pharmacological mechanism prediction of Lycii Fructus against postmenopausal osteoporosis
por: Wang, Jianbo, et al.
Publicado: (2023)